AS
Ascletis Pharma Inc.
ASCLF · OTC
$1.20 -0.83% (-$0.01)
1M -7.69%
Market Cap ¥8.42B
P/E Ratio -
Div. Yield -
ROE 17.44%
Piotroski F-Score Weak
1/9Valuation
23 /100
Expensive P/B 4.35x
P/S 4,263.77x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 8.66%
Rev. growth 66.82%
FCF growth N/A
Profitability
0 /100
Weak Net margin 17,745.60%
Op. margin 23,854.00%
FCF margin 16,746.40%
Quality
0 /100
Poor ROE 17.44%
ROA 16.96%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 15.05x
Int. coverage -2,949.78x
Debt/Equity 0.00x
Stability
13 /100
Unstable Rev. volatility 77.39%
EPS volatility 93.54%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ASCLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jinzi J. Wu
Employees
202
Headquarters
Hangzhou
Evenimente viitoare
30 MAR.
Earnings
Upcoming earnings report